Kathleen Byrne
Overview
Explore the profile of Kathleen Byrne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ankravs M, Udy A, Bellomo R, Presneill J, Adams L, Abdelhamid Y, et al.
Crit Care Resusc
. 2025 Jan;
26(4):249-254.
PMID: 39781498
Background: Patients in the intensive care unit (ICU) frequently develop hyperactive delirium, which may be accompanied by behaviour that increases clinical risks to themselves as well as other patients and...
2.
Brown E, Byrne K, Michos E, Leucker T, Marvel F, Jones S, et al.
Am J Prev Cardiol
. 2024 Jun;
18:100683.
PMID: 38828125
Objective: Assess the yield of genetic testing for pathogenic variants in and in individuals with personal and family histories suggestive of familial hypercholesterolemia. Methods: Retrospective review of patients seen in...
3.
Ankravs M, Udy A, Byrne K, Knowles S, Hammond N, Saxena M, et al.
Crit Care Resusc
. 2023 Dec;
22(4):355-360.
PMID: 38046881
To characterise the assessment and management of delirium in patients admitted to intensive care units (ICUs) in Australia and New Zealand. We conducted a multicentre observational point prevalence study across...
4.
Yarad E, Bates S, Butler M, Byrne K, Eastwood G, Grattan S, et al.
Aust Crit Care
. 2022 Oct;
36(1):35-43.
PMID: 36210280
Introduction: Intensive care unit clinical research is often implemented by specialised research coordinators (RCs). Clinical research activity within Australian and New Zealand intensive care units has escalated, particularly during the...
5.
Kokorelis C, Malone L, Byrne K, Morrow A, Rowe P
Clin Pediatr (Phila)
. 2022 Jul;
62(2):92-95.
PMID: 35883258
No abstract available.
6.
Hays L, Udy A, Adamides A, Anstey J, Bailey M, Bellapart J, et al.
J Clin Neurosci
. 2022 Apr;
99:349-358.
PMID: 35364437
Monitoring and optimisation of brain tissue oxygen tension (PbtO) has been associated with improved neurological outcome and survival in observational studies of severe traumatic brain injury (TBI). We carried out...
7.
Angus D, Buzgau A, Cheng A, Higgins A, Hullegie S, Lawler P, et al.
JAMA
. 2020 Sep;
324(13):1317-1329.
PMID: 32876697
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, And Participants: An...
8.
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumab
Dahagam C, Goud A, Abdelqader A, Hendrani A, Feinstein M, Qamar A, et al.
Future Cardiol
. 2016 Feb;
12(2):149-57.
PMID: 26911710
In this review, we examine alirocumab (Praluent(®)), a monoclonal antibody to PCSK9 and its role in reducing LDL-C levels. By comparing the results of various studies and trials we discuss...
9.
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumab
Dahagam C, Goud A, Abdelqader A, Hendrani A, Feinstein M, Qamar A, et al.
Future Cardiol
. 2016 Feb;
12(2):139-48.
PMID: 26911578
Patients with familial hypercholesterolemia or statin intolerance are especially challenging to manage since LDL cholesterol levels often remain considerably elevated despite clinicians' best efforts. With statins regarded as first-line pharmacologic...
10.
Cooper M, Walz K, Brown M, McDonald K, Dwyer D, Dowd P, et al.
J Emerg Nurs
. 2009 Nov;
35(6):580-3.
PMID: 19914494
No abstract available.